subject area of
- A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Academic Article
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
- An Overview of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
- Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
- Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II Academic Article
- Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
- DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE Academic Article
- Determination of the molecular weight of neuronectin, a conditioned medium-derived, substrate-binding neurite-extension factor: comparison with laminin using radiation-inactivation analysis Academic Article
- Effect of Fibrinogen Degradation Products and Lung Ground Substance on Surfactant Function Academic Article
- Extraction and analysis of glycosaminoglycans from intima-media of single rabbit aortae: effect of balloon catheter de-endothelialization on the content and profile of glycosaminoglycans Academic Article
- HIV-1 gp120 Induces TLR2- and TLR4-Mediated Innate Immune Activation in Human Female Genital Epithelium Academic Article
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways Academic Article
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Academic Article
- Heparan sulfate: Antithrombotic or not? Academic Article
- Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
- Heparin-induced thrombocytopenia and its treatment. Conference Paper
- Heparin-induced thrombocytopenia in intensive care patients Academic Article
- Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
- Heparin-induced thrombocytopenia. Academic Article
- Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Academic Article
- INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING Academic Article
- In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding Academic Article
- In vivo activity of a new heparinoid Academic Article
- In vivo activity of a new heparinoid. Academic Article
- Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Academic Article
- Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
- Low molecular weight heparins and heparinoids Academic Article
- Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Academic Article
- Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides Academic Article
- Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Academic Article
- Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
- Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients Academic Article
- Parenteral Anticoagulants Academic Article
- Parenteral Anticoagulants Academic Article
- Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfate Academic Article
- Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium. Academic Article
- Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
- Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s Academic Article
- Venous thromboembolism in heparin-induced thrombocytopenia Academic Article